- Summary
- Stats & Ratios
- Income Statement
- Balance Sheet
- Cash Flow
- Opinions
LIGAND PHARMACEUTICALS INCORPORATED
(NASDAQ:LGND)Key Stats & Ratios
| Valuation | |
| Market Cap | 258.24M |
| P/E | — |
| P/E (Trailing) | -12.00 |
| P/E (Forward) | — |
| Price/Sales | 12.27 |
| Price/Book | 135.00 |
| EPS | -0.21 |
| EPS Growth (ttm) | -100.00% |
| Fiscal Year | |
| Fiscal Year Ends | Dec 31 |
| Last Quarter | Jun 2008 |
| Profitability | |
| Operating Income | -31929000.00 |
| Net Income | -22549000.00 |
| Profit Margin (ttm) | -15.20% |
| Operating Margin (ttm) | -1.54% |
| Management Effectiveness | |
| Return on Assets (ttm) | -15.30% |
| Return on Equity (ttm) | — |
| EBIT Margin (ttm) | — |
| Memberships | |
| Russel 2000 | |
| SEC Filings | |
| Latest Form 10-Q (Quartely) | |
| Latest Form 10-K (Annual) | |
Financials
| Income Statement | |
| Total Enterprise Value | 245.43M |
| Revenue | 20.70M |
| Revenue/Share | 0.22 |
| Revenue Growth (ytd) | 109.50% |
| Annual Revenue Growth Rate (3Y) | -54.53% |
| Annual Income Growth Rate (3Y) | — |
| Earnings Growth (ytd) | -100.00% |
| Gross Operating Profit (ttm) | 21.87M |
| EBITDA | -32715000.00 |
| Diluted EPS (ttm) | -0.21 |
| Balance Sheet | |
| Total Cash | 12.34M |
| Total Cash/Share | 0.13 |
| Total Assets | 147.19M |
| Total Liabilities | 145.24M |
| Total Debt/Equity | — |
| Long Term Debt Common Equity Ratio | 0.09 |
| Current Ratio | 1.00 |
| Leverage Ratio | 75.00 |
| Book Value/Share | 0.02 |
| Cash Flow | |
| Cash Flow | -21371000.00 |
| Free Cash Flow | -19214000.00 |
| Cash Flow/Share | -0.23 |
| Free Cash Flow/Share | -0.20 |
Trading Information
| Stock Price History | |
| Beta | — |
| 52Wk Change | -41.40% |
| 52Wk Change Vs. Mkt | -12.00% |
| 52Wk High | 4.91 |
| 52Wk Low | 1.10 |
| 10 Day Moving Average | 2.66 |
| 200 Day Moving Average | 2.95 |
| Share Statistics | |
| Average Volume | 465.70K |
| Shares Outstanding | 94.94M |
| Shares Float | 92.82M |
| % Held by Insiders | 2.20% |
| % Held by Institutions | 88.30% |
| Shares Short (As of Dec 10, 2008) | 11.21M |
| Short Ratio | 21.20 |
| Short % of Float | 12.10% |
| Dividends & Splits | |
| Dividend Date | — |
| Dividend Yield | — |
| Dividend Amount | — |